4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Midazolam is combined with Gamma Hydroxybutyric Acid.
Acepromazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Aceprometazine.
Advertisement
Acetyl Sulfisoxazole
The metabolism of Midazolam can be decreased when combined with Acetyl sulfisoxazole.
Afatinib
The serum concentration of Afatinib can be decreased when it is combined with Midazolam.
Alfaxalone
The risk or severity of adverse effects can be increased when Midazolam is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Midazolam is combined with Alfentanil.
Alogliptin
The serum concentration of Midazolam can be increased when it is combined with Alogliptin.
alpha 1-Antitrypsin
The serum concentration of Midazolam can be increased when it is combined with Alpha-1-proteinase inhibitor.
Advertisement
Alpha 1-Proteinase Inhibitor, Human
The serum concentration of Midazolam can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alphaprodine
The risk or severity of adverse effects can be increased when Midazolam is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Midazolam.
AMBROXOL ACEFYLLINATE
The therapeutic efficacy of Midazolam can be decreased when used in combination with Ambroxol acefyllinate.
Ambroxol-Theophylline-7-Acetate
The therapeutic efficacy of Midazolam can be decreased when used in combination with Ambroxol acefyllinate.
Aminophylline
The therapeutic efficacy of Midazolam can be decreased when used in combination with Aminophylline.
Amiodarone
The metabolism of Midazolam can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Midazolam is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Midazolam is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Midazolam is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Midazolam is combined with Amoxapine.
Amprenavir
The serum concentration of Midazolam can be increased when it is combined with Amprenavir.
Antithrombin III
The serum concentration of Midazolam can be increased when it is combined with Antithrombin III human.
Antithrombin III, Human
The serum concentration of Midazolam can be increased when it is combined with Antithrombin III human.
Apalutamide
The serum concentration of Midazolam can be decreased when it is combined with Apalutamide.
Apixaban
The serum concentration of Midazolam can be increased when it is combined with Apixaban.
Aprepitant
The serum concentration of Midazolam can be increased when it is combined with Aprepitant.
Aprotinin
The serum concentration of Midazolam can be increased when it is combined with Aprotinin.
Argatroban
The serum concentration of Midazolam can be increased when it is combined with Argatroban.
Argatroban Anhydrous
The serum concentration of Midazolam can be increased when it is combined with Argatroban.
Aripiprazole
The risk or severity of adverse effects can be increased when Midazolam is combined with Aripiprazole.
Articaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Midazolam is combined with Asenapine.
Asunaprevir
The serum concentration of Midazolam can be decreased when it is combined with Asunaprevir.
Atazanavir
The serum concentration of Midazolam can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Midazolam can be decreased when combined with Atomoxetine.
Atorvastatin
The serum concentration of Midazolam can be increased when it is combined with Atorvastatin.
Azelastine
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Midazolam is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Midazolam is combined with Barbital.
Benazepril
The serum concentration of Midazolam can be increased when it is combined with Benazepril.
Benoxinate
The risk or severity of adverse effects can be increased when Midazolam is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Midazolam is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Midazolam is combined with Benzyl alcohol.
Bivalirudin
The serum concentration of Midazolam can be increased when it is combined with Bivalirudin.
Boceprevir
The serum concentration of Midazolam can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Midazolam can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Midazolam can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Midazolam can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Midazolam.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Midazolam.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be decreased when it is combined with Midazolam.
Brexpiprazole
The risk or severity of adverse effects can be increased when Midazolam is combined with Brexpiprazole.
Brigatinib
The serum concentration of Midazolam can be decreased when it is combined with Brigatinib.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Bromazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Bromazepam.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Midazolam.
Bromperidol
The risk or severity of adverse effects can be increased when Midazolam is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Bupivacaine.
Buprenorphine
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Midazolam.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Midazolam.
Butalbital
The risk or severity of adverse effects can be increased when Midazolam is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Midazolam is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Midazolam is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Midazolam.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Midazolam.
Captopril
The serum concentration of Midazolam can be increased when it is combined with Captopril.
Carbamazepine
The metabolism of Midazolam can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Midazolam is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Midazolam is combined with Carisoprodol.
Ceritinib
The serum concentration of Midazolam can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Midazolam.
Cetirizine
The risk or severity of adverse effects can be increased when Midazolam is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Midazolam is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Midazolam.
Chlormethiazole
The risk or severity of adverse effects can be increased when Midazolam is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Midazolam is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Midazolam is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Midazolam.
Chlorprothixene
The risk or severity of adverse effects can be increased when Midazolam is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Midazolam is combined with Chlorzoxazone.
Cilastatin
The serum concentration of Midazolam can be increased when it is combined with Cilastatin.
Cilazapril
The serum concentration of Midazolam can be increased when it is combined with Cilazapril.
Citalopram
The metabolism of Midazolam can be decreased when combined with Citalopram.
Clarithromycin
The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Midazolam can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Midazolam is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Midazolam is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Midazolam is combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Midazolam is combined with Clonidine.
Clopidogrel
The metabolism of Midazolam can be decreased when combined with Clopidogrel.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Midazolam.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Midazolam.
Clotrimazole
The metabolism of Midazolam can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.
Cobicistat
The serum concentration of Midazolam can be increased when it is combined with Cobicistat.
Cocaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Midazolam.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Midazolam.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Midazolam.
Crizotinib
The metabolism of Midazolam can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Midazolam can be decreased when combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Midazolam is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Midazolam is combined with Cyclobenzaprine.
Cyclosporine
The metabolism of Midazolam can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Midazolam is combined with Cyproheptadine.
Dabigatran Etexilate
The serum concentration of Dabigatran etexilate can be decreased when it is combined with Midazolam.
Dabrafenib
The serum concentration of Midazolam can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Midazolam is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Midazolam is combined with Dapiprazole.
Darunavir
The serum concentration of Midazolam can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Midazolam can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Midazolam can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Midazolam can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Midazolam can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Midazolam is combined with Desflurane.
Desipramine
The metabolism of Midazolam can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Midazolam is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Midazolam is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Midazolam is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Midazolam is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Midazolam is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Midazolam is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Midazolam is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Midazolam is combined with Dihydrocodeine.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Midazolam.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Midazolam.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Midazolam.
Diltiazem
The metabolism of Midazolam can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Midazolam is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Midazolam is combined with Diphenoxylate.
Doxepin
The risk or severity of adverse effects can be increased when Midazolam is combined with Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Midazolam.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Midazolam.
Doxycycline
The metabolism of Midazolam can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Midazolam can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Dronedarone
The metabolism of Midazolam can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Duloxetine
The risk or severity of adverse effects can be increased when Midazolam is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Midazolam is combined with Dyclonine.
Dyphylline
The therapeutic efficacy of Midazolam can be decreased when used in combination with Dyphylline.
Edoxaban
The serum concentration of Midazolam can be increased when it is combined with Edoxaban.
Efavirenz
The risk or severity of adverse effects can be increased when Midazolam is combined with Efavirenz.
Enalapril
The serum concentration of Midazolam can be increased when it is combined with Enalapril.
Enalaprilat
The serum concentration of Midazolam can be increased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The serum concentration of Midazolam can be increased when it is combined with Enalaprilat.
Enflurane
The risk or severity of adverse effects can be increased when Midazolam is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Midazolam is combined with Entacapone.
Enzalutamide
The serum concentration of Midazolam can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Midazolam.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Midazolam.
Erythromycin
The serum concentration of Midazolam can be increased when it is combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Midazolam is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Midazolam.
Ethanol
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Midazolam is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Midazolam is combined with Etomidate.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Midazolam.
Ezogabine
The risk or severity of adverse effects can be increased when Midazolam is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Midazolam is combined with Felbamate.
Fentanyl
The risk or severity of adverse effects can be increased when Midazolam is combined with Fentanyl.
Fexofenadine
The risk or severity of adverse effects can be increased when Midazolam is combined with Fexofenadine.
Fibrinolysis Inhibitor
The serum concentration of Midazolam can be increased when it is combined with Aprotinin.
Flibanserin
The risk or severity of adverse effects can be increased when Midazolam is combined with Flibanserin.
Fluconazole
The metabolism of Midazolam can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Midazolam is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Midazolam is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Midazolam is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Midazolam.
Flurazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Midazolam is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Midazolam is combined with Fluticasone propionate.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Midazolam.
Fluvoxamine
The metabolism of Midazolam can be decreased when combined with Fluvoxamine.
Fosamprenavir
The serum concentration of Midazolam can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Midazolam can be increased when it is combined with Fosaprepitant.
Fosinopril
The serum concentration of Midazolam can be increased when it is combined with Fosinopril.
Fosphenytoin
The serum concentration of Fosphenytoin can be increased when it is combined with Midazolam.
Fospropofol
The risk or severity of adverse effects can be increased when Midazolam is combined with Fospropofol.
Fusidate
The serum concentration of Midazolam can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Midazolam can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Midazolam is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Midazolam is combined with Gabapentin Enacarbil.
Ginkgo biloba extract
The serum concentration of Midazolam can be decreased when it is combined with Ginkgo biloba.
Glutethimide
The risk or severity of adverse effects can be increased when Midazolam is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Midazolam is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Midazolam.
Halothane
The risk or severity of adverse effects can be increased when Midazolam is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Midazolam is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Midazolam is combined with Hexobarbital.
Hyaluronidase
The therapeutic efficacy of Midazolam can be decreased when used in combination with Hyaluronidase.
Hyaluronidase, Ovine
The therapeutic efficacy of Midazolam can be decreased when used in combination with Hyaluronidase.
Hydrocodone
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Midazolam.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Hypoxis hemerocallidea root extract
The serum concentration of Midazolam can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Midazolam.
Idelalisib
The serum concentration of Midazolam can be increased when it is combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Midazolam is combined with Iloperidone.
Imatinib
The metabolism of Midazolam can be decreased when combined with Imatinib.
Imidapril
The serum concentration of Midazolam can be increased when it is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Imipramine.
Indinavir
The serum concentration of Midazolam can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Midazolam can be increased when it is combined with Indinavir.
Isavuconazole
The serum concentration of Midazolam can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Midazolam can be decreased when combined with Isavuconazonium.
Isocarboxazid
The therapeutic efficacy of Midazolam can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Midazolam is combined with Isoflurane.
Isoflurophate
The serum concentration of Midazolam can be increased when it is combined with Isoflurophate.
Isradipine
The metabolism of Midazolam can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Midazolam can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Midazolam can be increased when it is combined with Ivacaftor.
Ixazomib
The serum concentration of Midazolam can be increased when it is combined with Ixazomib.
Josamycin
The serum concentration of Midazolam can be increased when it is combined with Josamycin.
Ketamine
The risk or severity of adverse effects can be increased when Midazolam is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Ketazolam.
Ketoconazole
The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Midazolam is combined with Lamotrigine.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Midazolam.
Lepirudin
The serum concentration of Midazolam can be increased when it is combined with Lepirudin.
Levetiracetam
The risk or severity of adverse effects can be increased when Midazolam is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Midazolam is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Midazolam is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Midazolam is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Midazolam is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Midazolam is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Midazolam is combined with Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Lidocaine.
Linagliptin
The serum concentration of Midazolam can be increased when it is combined with Linagliptin.
Lisinopril
The serum concentration of Midazolam can be increased when it is combined with Lisinopril.
Lisinopril Anhydrous
The serum concentration of Midazolam can be increased when it is combined with Lisinopril.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Midazolam.
Lithium
The risk or severity of adverse effects can be increased when Midazolam is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Midazolam is combined with Lithium.
Lofexidine
The therapeutic efficacy of Midazolam can be increased when used in combination with Lofexidine.
Lopinavir
The serum concentration of Midazolam can be increased when it is combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Midazolam is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Midazolam.
Lormetazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Lormetazepam.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Midazolam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Midazolam.
Luliconazole
The serum concentration of Midazolam can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Midazolam can be decreased when it is combined with Lumacaftor.
Lurasidone
The risk or severity of adverse effects can be increased when Midazolam is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Midazolam can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Midazolam can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Midazolam is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Midazolam is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Midazolam is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Midazolam.
Mephobarbital
The risk or severity of adverse effects can be increased when Midazolam is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Midazolam.
Mesoridazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Midazolam is combined with Metaxalone.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Midazolam.
Methadone
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Midazolam is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Midazolam is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Midazolam is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Midazolam is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Midazolam.
Methotrimeprazine
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Midazolam is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Midazolam is combined with Methsuximide.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Midazolam.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Midazolam.
Metylperon
The risk or severity of adverse effects can be increased when Midazolam is combined with Melperone.
Metyrosine
Midazolam may increase the sedative activities of Metyrosine.
Mifepristone
The serum concentration of Midazolam can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Midazolam is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Mirtazapine
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Midazolam can be decreased when it is combined with Mitotane.
Moexipril
The serum concentration of Midazolam can be increased when it is combined with Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Midazolam is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Midazolam.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Nalbuphine
The risk or severity of adverse effects can be increased when Midazolam is combined with Nalbuphine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Midazolam.
Nefazodone
The metabolism of Midazolam can be decreased when combined with Nefazodone.
Nelfinavir
The serum concentration of Midazolam can be increased when it is combined with Nelfinavir.
Netupitant
The serum concentration of Midazolam can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Midazolam can be increased when combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Midazolam.
Nilotinib
The metabolism of Midazolam can be decreased when combined with Nilotinib.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Midazolam.
Nitrazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Midazolam is combined with Nitrous oxide.
Nordazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Midazolam is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Midazolam is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Midazolam is combined with Nortriptyline.
O-PHENANTHROLINE
The serum concentration of Midazolam can be increased when it is combined with 1,10-Phenanthroline.
Olanzapine
The risk or severity of adverse effects can be increased when Midazolam is combined with Olanzapine.
Olaparib
The metabolism of Midazolam can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Midazolam is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Midazolam is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Midazolam is combined with Opium.
Orphenadrine
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Midazolam can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Oxazepam.
Oxprenolol
The risk or severity of adverse effects can be increased when Midazolam is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Midazolam.
Oxymorphone
The risk or severity of adverse effects can be increased when Midazolam is combined with Oxymorphone.
Palbociclib
The serum concentration of Midazolam can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Midazolam is combined with Paliperidone.
Paraldehyde
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Midazolam.
Paroxetine
The metabolism of Midazolam can be decreased when combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Midazolam.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Midazolam.
Pentobarbital
The metabolism of Midazolam can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Perazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Perazine.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Midazolam.
Perindopril
The serum concentration of Midazolam can be increased when it is combined with Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Perphenazine.
Phenobarbital
The metabolism of Midazolam can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Midazolam is combined with Phenoxyethanol.
Phenytoin
The serum concentration of Phenytoin can be increased when it is combined with Midazolam.
Pimozide
The risk or severity of adverse effects can be increased when Midazolam is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Midazolam is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Midazolam is combined with Piritramide.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Midazolam.
Pizotyline
The risk or severity of adverse effects can be increased when Midazolam is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Midazolam is combined with Pomalidomide.
Posaconazole
The metabolism of Midazolam can be decreased when combined with Posaconazole.
Pramipexole
Midazolam may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Midazolam is combined with Pramocaine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Midazolam.
Prazepam
The risk or severity of adverse effects can be increased when Midazolam is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Midazolam can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Prilocaine.
Primidone
The metabolism of Midazolam can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Midazolam.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Midazolam.
Promethazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Proparacaine.
Propofol
The serum concentration of Propofol can be increased when it is combined with Midazolam.
Propoxyphene
The risk or severity of adverse effects can be increased when Midazolam is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Midazolam is combined with Protriptyline.
Quazepam
The serum concentration of Midazolam can be increased when it is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Midazolam is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Midazolam is combined with Quetiapine.
Quinapril
The serum concentration of Midazolam can be increased when it is combined with Quinapril.
Racecadotril
The serum concentration of Midazolam can be increased when it is combined with Racecadotril.
Ramelteon
The risk or severity of adverse effects can be increased when Midazolam is combined with Ramelteon.
Ramipril
The serum concentration of Midazolam can be increased when it is combined with Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Midazolam.
Remifentanil
The risk or severity of adverse effects can be increased when Midazolam is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Midazolam is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Midazolam.
Ribociclib
The serum concentration of Midazolam can be increased when it is combined with Ribociclib.
Rifabutin
The metabolism of Midazolam can be increased when combined with Rifabutin.
Rifampin
The metabolism of Midazolam can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Midazolam can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Midazolam.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Midazolam.
Risperidone
The risk or severity of adverse effects can be increased when Midazolam is combined with Risperidone.
Ritonavir
The serum concentration of Midazolam can be increased when it is combined with Ritonavir.
Rivaroxaban
The serum concentration of Midazolam can be increased when it is combined with Rivaroxaban.
Ropinirole
Midazolam may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Ropivacaine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Midazolam.
Rotigotine
Midazolam may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Midazolam can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Midazolam.
Saquinavir
The serum concentration of Midazolam can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Midazolam can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Midazolam can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Midazolam can be increased when it is combined with Saxagliptin.
Saxagliptin Anhydrous
The serum concentration of Midazolam can be increased when it is combined with Saxagliptin.
Scopolamine
The risk or severity of adverse effects can be increased when Midazolam is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Midazolam is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Midazolam.
Sertindole
The risk or severity of adverse effects can be increased when Midazolam is combined with Sertindole.
Sertraline
The metabolism of Midazolam can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Midazolam is combined with Sevoflurane.
Sildenafil
The metabolism of Midazolam can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Midazolam.
Siltuximab
The serum concentration of Midazolam can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Midazolam can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Midazolam.
Sitagliptin
The serum concentration of Midazolam can be increased when it is combined with Sitagliptin.
Sitagliptin Phosphate
The serum concentration of Midazolam can be increased when it is combined with Sitagliptin.
Sodium Oxybate
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Sofosbuvir
The serum concentration of Sofosbuvir can be decreased when it is combined with Midazolam.
Sorafenib
The metabolism of Midazolam can be decreased when combined with Sorafenib.
Spirapril
The serum concentration of Midazolam can be increased when it is combined with Spirapril.
ST. JOHN'S WORT EXTRACT
The serum concentration of Midazolam can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Midazolam is combined with Sufentanil.
Sulfisoxazole
The metabolism of Midazolam can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Midazolam is combined with Sulpiride.
Suvorexant
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Tasimelteon
The risk or severity of adverse effects can be increased when Midazolam is combined with Tasimelteon.
Teduglutide
The serum concentration of Midazolam can be increased when it is combined with Teduglutide.
Telaprevir
The serum concentration of Midazolam can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Midazolam can be increased when it is combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Midazolam.
Tetrabenazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Midazolam is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Midazolam is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Thalidomide
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The therapeutic efficacy of Midazolam can be decreased when used in combination with Theophylline.
Theophylline anhydrous
The therapeutic efficacy of Midazolam can be decreased when used in combination with Theophylline.
Thiamylal
The risk or severity of adverse effects can be increased when Midazolam is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Midazolam is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Midazolam is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Midazolam.
Thiotepa
The metabolism of Midazolam can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Midazolam is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Midazolam is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Midazolam is combined with Tiapride.
Ticlopidine
The metabolism of Midazolam can be decreased when combined with Ticlopidine.
Tipranavir
The serum concentration of Midazolam can be increased when it is combined with Tipranavir.
Tizanidine
The risk or severity of adverse effects can be increased when Midazolam is combined with Tizanidine.
Tocilizumab
The serum concentration of Midazolam can be decreased when it is combined with Tocilizumab.
Tolcapone
The risk or severity of adverse effects can be increased when Midazolam is combined with Tolcapone.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Midazolam.
Topiramate
The risk or severity of adverse effects can be increased when Midazolam is combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Midazolam.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Midazolam.
Trandolapril
The serum concentration of Midazolam can be increased when it is combined with Trandolapril.
Tranylcypromine
The risk or severity of adverse effects can be increased when Midazolam is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Midazolam is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Midazolam is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Midazolam is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Midazolam is combined with Triprolidine.
Urethane
The risk or severity of adverse effects can be increased when Midazolam is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Midazolam is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Midazolam is combined with Valproic Acid.
Vemurafenib
The serum concentration of Midazolam can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Midazolam can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Midazolam can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Midazolam is combined with Vigabatrin.
Vildagliptin
The serum concentration of Midazolam can be increased when it is combined with Vildagliptin.
Vincristine
The serum concentration of Vincristine can be decreased when it is combined with Midazolam.
Voriconazole
The metabolism of Midazolam can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Midazolam is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Midazolam is combined with Xylazine.
Yohimbine
The therapeutic efficacy of Midazolam can be decreased when used in combination with Yohimbine.
Zaleplon
The risk or severity of adverse effects can be increased when Midazolam is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Midazolam is combined with Ziconotide.
Ziprasidone
The metabolism of Midazolam can be decreased when combined with Ziprasidone.
Zofenopril
The serum concentration of Midazolam can be increased when it is combined with Zofenopril.
Zolpidem
Midazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Midazolam is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Midazolam is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Midazolam is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Midazolam is combined with Zuclopenthixol.
